PHASE-II TRIALS OF THE SEROTONIN ANTAGONIST GR38032F FOR THE CONTROL OF VOMITING CAUSED BY CISPLATIN

被引：110

作者：

KRIS, MG ^{[1
]}

GRALLA, RJ ^{[1
]}

CLARK, RA ^{[1
]}

TYSON, LB ^{[1
]}

机构：

[1] CORNELL UNIV,MED CTR,COLL MED,NEW YORK,NY 10021

来源：

关键词：

D O I：

10.1093/jnci/81.1.42

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：42 / 46

页数：5

共 18 条

[1] BINOMIAL CONFIDENCE-INTERVALS
BLYTH, CR
STILL, HA
[J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1983, 78 (381) : 108 - 116
[2] PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE
BRADLEY, PB
ENGEL, G
FENIUK, W
FOZARD, JR
HUMPHREY, PPA
MIDDLEMISS, DN
MYLECHARANE, EJ
RICHARDSON, BP
SAXENA, PR
[J]. NEUROPHARMACOLOGY, 1986, 25 (06) : 563 - 576
[3] BRITTAIN R T, 1987, British Journal of Pharmacology, V90, p87P
[4] CLARK R, 1985, ONCOL NURS FORUM S, V12, P96
[5] COSTALL B, 1987, British Journal of Pharmacology, V90, p90P
[6] PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST
CUNNINGHAM, D
POPLE, A
FORD, HT
HAWTHORN, J
GAZET, JC
CHALLONER, T
COOMBES, RC
[J]. LANCET, 1987, 1 (8548) : 1461 - 1463
[7] NABILONE - AN EFFECTIVE ANTI-EMETIC AGENT IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY
EINHORN, L
[J]. CANCER TREATMENT REVIEWS, 1982, 9 : 55 - 61
[8] GRALLA RJ, 1984, CANCER TREAT REP, V68, P163
[9] ANTI-EMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE - RANDOMIZED TRIALS WITH PLACEBO AND PROCHLORPERAZINE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
GRALLA, RJ
ITRI, LM
PISKO, SE
SQUILLANTE, AE
KELSEN, DP
BRAUN, DW
BORDIN, LA
BRAUN, TJ
YOUNG, CW
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (16) : 905 - 909
[10] GRUNBERG SM, 1988, P ASCO, V7, P279